GlaxoSmithKline
Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older
25 Mar 2025
Blujepa is the first in a new class of oral antibiotics for uUTIs in nearly 30 years.
25 March 2025
25 Mar 2025
New collaboration aims to deepen understanding of neurodegeneration using the UK’s unique health data ecosystem.
GSK, UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to collaborate on first-of-its-kind dementia research initiative
25 Mar 2025
New collaboration aims to deepen understanding of neurodegeneration using the UK’s unique health data ecosystem.
ViiV Healthcare continues to deliver long-acting injectable HIV innovation with late-breaking data and real-world insights across pipeline and portfolio at CROI 2025
10 Mar 2025
Real-world and implementation data highlight effectiveness of Cabenuva and Apretude.
09 March 2025
10 Mar 2025
Real-world and implementation data highlight effectiveness of Cabenuva and Apretude.
06 March 2025
06 Mar 2025
17 abstracts to evaluate unmet medical need and approaches to RSV prevention in adults.
GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults
06 Mar 2025
17 abstracts to evaluate unmet medical need and approaches to RSV prevention in adults.
Depemokimab applications accepted for review by the US FDA for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps (CRSwNP)
03 Mar 2025
If approved, depemokimab will be the first ultra-long-acting biologic with 6-month dosing
Depemokimab delivers clinically meaningful and statistically significant improvements for patients with chronic rhinosinusitis with nasal polyps (CRSwNP)
03 Mar 2025
ANCHOR-1 and ANCHOR-2 phase III trials show improvements in nasal polyp size and obstruction for depemokimab with twice-yearly dosing
03 March 2025
03 Mar 2025
ANCHOR-1 and ANCHOR-2 phase III trials show improvements in nasal polyp size and obstruction for depemokimab with twice-yearly dosing
Featured
The history of safety glass
By Kiron Kasbekar | 26 Mar 2025
You probably already knew that the world’s VIPs move around in cars with bullet-proof glass windscreen and windows. But did you know that ‘bulletproof glass’ is not really bulletproof?
German silver: used in cutlery, music, electricals - but it’s not silver
By Kiron Kasbekar | 20 Mar 2025
This material, which was first developed in China, not Germany, and is an alloy of copper, nickel and zinc, has lost its sheen in home uses, but finds favor in electrical engineering.
Pioneers – the Wrights and Glenn Curtiss launched the aircraft industry
By Kiron Kasbekar | 17 Mar 2025
First Orville and Wilbur Wright flew their plane, the ‘Wright Flyer’, from near a small town called Kitty Hawk. Then Glenn Curtiss built planes with a very different system of controls, which has lasted until now.
What do aircraft have in common with bicycles and motorcycles?
By Kiron Kasbekar | 17 Mar 2025
From chains and sprockets to direct drives—If someone asked you what aircraft have in common with bicycles and motorcycles, how would you respond?
Radar’s ancestors: From sound mirrors to modern detection technology
By Kiron Kasbekar | 11 Mar 2025
Radar has become a well-settled technology today, especially in the field of navigation.
Nokia Bell Labs: innovations in communication, computing, technology
By Omar Almeida | 08 Mar 2025
Bell Laboratories, or Bell labs, which has now become Nokia Bell Labs, is one of the most renowned research and development organizations in the history of science and technology.
Company story – Quaker Oats
By Kiron Kasbekar | 08 Mar 2024
Quaker Oats is a company whose products I remember from my childhood days. Years before a foreign exchange crisis caused the Indian government to impose curbs on consumer product imports, we used to see a host of foreign brands in the Indian market. Including Quaker Oats, which I remember eating when I was a child, and which has been available for the past two decades or more.
How Quaker Oats grabbed customers’ attention
By Kiron Kasbekar | 07 Mar 2024
Quaker Oats, the American food products giant that was created in 1901 through the merger of many older oat millers, and was acquired by a bigger foods giant, Pepsi, in 2001, has been an innovative company. One example of its innovativeness shows in its packaging – the cereal box it launched in 1915.
Company story – Cunard Line
By Kiron Kasbekar | 12 Jan 2024
The Cunard Line started its life in Glasgow in 1839 as the British and North American Royal Mail Steam-Packet Company when Samuel Cunard was awarded the first British transatlantic steamship mail contract.
